Question 1

What is the catalog number for Boc-Leu-Ser-Thr-Arg-AMC?

Accepted Answer

The catalog number for Boc-Leu-Ser-Thr-Arg-AMC is orb2566813.

Question 2

What sizes are available for Boc-Leu-Ser-Thr-Arg-AMC?

Accepted Answer

Boc-Leu-Ser-Thr-Arg-AMC is available in the following size(s): 50 mg, 100 mg, 25 mg.

Question 3

How many pack sizes does Boc-Leu-Ser-Thr-Arg-AMC come in?

Accepted Answer

Boc-Leu-Ser-Thr-Arg-AMC is available in 3 different pack sizes.

Question 4

Is Boc-Leu-Ser-Thr-Arg-AMC in stock?

Accepted Answer

Boc-Leu-Ser-Thr-Arg-AMC is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Boc-Leu-Ser-Thr-Arg-AMC used for?

Accepted Answer

Boc-Leu-Ser-Thr-Arg-AMC is a fluorogenic peptide substrate where cleavage by proteases releases the fluorescent AMC moiety. It is widely used in vitro for the continuous assay of protease activity, including that of thrombin and trypsin, in biochemical and pharmacological research.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 8

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Boc-Leu-Ser-Thr-Arg-AMC

Product Specifications

CAS Number

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

MGAT1 (NM_001114618) Human Over-expression Lysate

PKN beta (PKN3) (C-term) Rabbit Polyclonal Antibody

APOE4 Human

APOE4 Human

APOE4 Human

Human CELA2A activation kit by CRISPRa